High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
HHS-NIH11
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the po…
MINORITY SERVING INSTITUTIONS PARTNERSHIP PROGRAM (MSIPP) CONSORTIA GRANT PROGRAM (CGP)
DOE-NNSA
The intent of this funding opportunity is to award new or renewal grant awards to consortia consisting of Minority Serving Institution (MSIs) and Tribal Colleges and Universities (TCUs) to with a foc…
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research …
HHS-NIH11
This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and car…
Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed)
HHS-NIH11
This Notice of Funding Opportunity (NOFO) invites applications to usethe NIH INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) to access resou…
Systems-Based Approaches to Improve Patient Safety by Improving Healthcare Worker Safety and Well-Being (R01 Clinical …
HHS-AHRQ
The purpose of this Notice of Funding Opportunity (NOFO) is to advance system-level approaches to improve patient safety by improving healthcare worker safety and well-being. Patient safety cannot be…
Minor Use Minor Species Development of Drugs (R01)
HHS-FDA
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from instit…
Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial …
HHS-FDA
FDA announces the availability of fiscal year (FY) 2024 funds to support one or more projects to 1) collect antimicrobial use data from diverse animal sectors, including domestic livestock, poultry, …
Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)
HHS-FDA
The purpose of this funding opportunity is to support the research and development necessary to advance non-invasive (e.g., quantitative tomography-based) technologies, including the development of a…
Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
HHS-FDA
The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreem…
Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial …
HHS-FDA
The objective of this research proposal is to develop physiologically based pharmacokinetic (PBPK) model-based mechanistic in vitro in vivo correlations (IVIVCs) for two major types of long acting in…
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not …
HHS-NIH11
The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, indepen…
National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)
HHS-NIH11
The goal of the NIGMS Predoctoral Basic Biomedical Sciences Research Training Program is to develop a pool of well-trained scientists available to address the Nations biomedical research agenda. Spec…